Navigation Links
Amylin Pharmaceuticals Reports 2010 Financial Results
Date:1/26/2011

SAN DIEGO, Jan. 26, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2010. The Company reported total revenue of $174.2 million for the quarter ended December 31, 2010, including net product sales of $162.3 million and revenue under collaborative agreements of $11.9 million. Non-GAAP operating income was $22.9 million for the quarter ended December 31, 2010, compared to non-GAAP operating loss of $17.0 million for the same period in 2009. Net loss, excluding restructuring charges, was $11.9 million, or $0.08 per share for the quarter ended December 31, 2010, compared to $44.7 million, or $0.32 per share for the same period in 2009. GAAP net loss was $19.2 million, or $0.13 per share for the quarter ended December 31, 2010, compared to $50.3 million, or $0.35 per share for the same period in 2009.

For the year ended December 31, 2010, the Company reported total revenue of $668.8 million, which includes net product sales of $651.1 million, and revenues under collaborative agreements of $17.7 million. Non-GAAP operating loss was $4.4 million for the year, compared to a loss of $58.7 million for 2009. Net loss, excluding restructuring charges, was $135.5 million, or $0.94 per share, for the year ended December 31, 2010, compared to $169.3 million, or $1.20 per share, for 2009. GAAP net loss was $152.3 million, or $1.06 per share, for the year ended December 31, 2010, compared to $186.3 million, or $1.32 per share for 2009. At December 31, 2010 the Company held cash, cash equivalents, short-term investments and restricted cash of $457.7 million.

"In 2010, Amylin achieved results that demonstrate our continued commitment to strong financial discipline and operational efficiency," said Daniel M. Bradbury, president and chief executive officer, Amylin Pharmaceuticals. "This year we wi
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
2. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
4. Amylin Pharmaceuticals Reports Third Quarter Financial Results
5. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
6. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
7. Amylin Pharmaceuticals to Webcast Third Quarter Results
8. Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010
9. Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
10. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
11. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer").  On ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
... InfoLogix, Inc. (Pink Sheets: IFLG ), ... the healthcare and commercial industries, announced today that it ... Faire and Regional Conference, sponsored by HIMSS South Florida ... Grand Hotel in Davies, FL (situated North of Miami) ...
... Mass., Oct. 25 GENFIT (Alternext: ALGFT; ISIN: FR0004163111), ... and development, focusing on the early diagnosis and preventive ... it has been selected by Windhover as one of ... the cardiovascular/metabolic category. This announcement is part of the ...
Cached Medicine Technology:InfoLogix to Present at South Florida Healthcare Trade Faire & Regional Conference 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 3
(Date:5/23/2013)... PHILADELPHIA, May 24, 2013 -- High blood glucose is ... of intensive insulin therapy (IIT) to control hyperglycemia is ... does not show a consistent benefit and even shows ... the American College of Physicians, (ACP) Clinical Guidelines Committee ... the American Journal of Medical Quality . , ...
(Date:5/23/2013)... Littleton, CO (PRWEB) May 23, 2013 ... environment, Special Operations Forces and law enforcement need an ... Night Vision Security Enhancer, Night VISER , is ... illuminator and motion sensing system to increase border and ... for Night VISER have more than tripled over the ...
(Date:5/23/2013)... May 24, 2013 In his pulse-quickening novel, ... the question, “Do you trust your government?” , In the ... killed en route to London ’s Heathrow Airport. His ... is left waiting for him to arrive at his ... death surfaces, Alan has doubts about the government’s report. When ...
(Date:5/23/2013)... Orange County film studio and visual effects ... light leaks for Apple's Final Cut Pro X today. ... no longer have to worry about matching up the movement ... Said Christina Austin, CEO of Pixel Film Studios, "You have ... look." , ProLeak from Pixel Film Studios allows users to ...
(Date:5/23/2013)... Branford, CT (PRWEB) May 23, 2013 ... patient satisfaction and perception management tools, and ASCA, ... to develop the new ASCA Benchmarking Program. ... in surveying technology and national benchmarking experience to ... with a comprehensive, state-of-the-art benchmarking tool. , “Voyance ...
Breaking Medicine News(10 mins):Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3Health News:New Book “The AIDS Covenant” by Roy Harris Delivers Intriguing, Captivating Story 2Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3
... Researchers at Cambridge University in the UK have discovered ... play a significant role in triggering breast cancer in ... new methods of targeting younger women at higher-than-average risk ... with mammography before they reach 50 - the age ...
... of 'monkey see, monkey do.' Researchers at Ohio University ... red, they began to develop red and orange skin and ... such as macaques and leaf monkeys, all have trichromatic vision, ... red colors. Primatologists have disagreed about whether this type of ...
... a say in how they quit are more likely to ... new research at the University of Rochester . ... the University of Rochester School of Medicine and Dentistry, will ... demonstrate patient involvement in a quit plan leads to smokers ...
... an enzyme called Cdk5 in their brains by using the ... adept at learning and quicker at figuring out the changes ... ,"Its pretty rare that you make mice smarter, so ... senior study author Dr. James Bibb, Assistant Professor of Psychiatry, ...
... Published today in the American Diabetes Association journal Diabetes ... that the care of elderly patients with type 1insulin ... facilities fails to meet ADA Standards of Care. ... Intensity of Care?, a study authored Jay Shubrook, D.O., ...
... are the bad guys that help bacterial pathogens do their ... system. In essence, they knock down the front door of ... ,Now, researchers at the University of California, San Diego (UCSD) ... an effector protein called YpkA, one of several effectors of ...
Cached Medicine News:Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3Health News:Color Vision Drove Primates to Develop Red Skin and Hair, Study Finds 2Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2Health News:Scientist Found New Mechanism for Brain Learning 2Health News:Diabetics in Nursing Homes Need Improved Care 2Health News:Diabetics in Nursing Homes Need Improved Care 3Health News:How Plague-Causing Bacteria Disarm Host Defense 2
... designed specifically for posteror ... injection of silicone oil ... Special high pressure tubing ... cannula. May also be ...
Product designed specifically for posteror segment surgical procedures. Facilitates posterior segment infusion. Flexible tubing 10in (25cm)....
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 23G x4 1/2in (.60mm x 11cm) Silicone tubing, length 14in (35cm), ID: .012in (.30mm) OD: .025in (.60mm...
...
Medicine Products: